Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maroof Hasan

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Oligonucleotides|April 28, 2007
Self-assembling supramolecular complexes by single-stranded extension from plasmid DNAMathias G Svahn, Maroof Hasan, Valeria Sigot, et al.
Biomolecular Engineering|September 8, 2005
Increased stability and specificity through combined hybridization of peptide nucleic acid (PNA) and locked nucleic acid (LNA) to supercoiled plasmids for PNA-anchored "Bioplex" formationKarin E Lundin, Maroof Hasan, Pedro M Moreno, et al.
Nature Immunology|November 20, 2012
Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genesMaroof Hasan, James Koch, Dinesh Rakheja, et al.
Immunity|September 1, 2015
Cytosolic Nuclease TREX1 Regulates Oligosaccharyltransferase Activity Independent of Nuclease Activity to Suppress Immune ActivationMaroof Hasan, Charles S Fermaintt, Ningguo Gao, et al.
Leukemia Research|April 2, 2024
Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AMLAlberto Risueño, Wendy L See, Iryna Bluemmert, et al.
Cell Reports|November 10, 2021
TNF leads to mtDNA release and cGAS/STING-dependent interferon responses that support inflammatory arthritisJoschka Willemsen, Marie-Therese Neuhoff, Thomas Hoyler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 22, 2010
Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNASandesh Subramanya, Myriam Armant, Janelle R Salkowitz, et al.
The Lancet. Oncology|October 21, 2021
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trialCourtney D DiNardo, Andre C Schuh, Eytan M Stein, et al.
Blood|June 17, 2022
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trialStéphane de Botton, Pau Montesinos, Andre C Schuh, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Oligonucleotides|April 28, 2007
Self-assembling supramolecular complexes by single-stranded extension from plasmid DNAMathias G Svahn, Maroof Hasan, Valeria Sigot, et al.
Biomolecular Engineering|September 8, 2005
Increased stability and specificity through combined hybridization of peptide nucleic acid (PNA) and locked nucleic acid (LNA) to supercoiled plasmids for PNA-anchored "Bioplex" formationKarin E Lundin, Maroof Hasan, Pedro M Moreno, et al.
Nature Immunology|November 20, 2012
Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genesMaroof Hasan, James Koch, Dinesh Rakheja, et al.
Immunity|September 1, 2015
Cytosolic Nuclease TREX1 Regulates Oligosaccharyltransferase Activity Independent of Nuclease Activity to Suppress Immune ActivationMaroof Hasan, Charles S Fermaintt, Ningguo Gao, et al.
Leukemia Research|April 2, 2024
Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AMLAlberto Risueño, Wendy L See, Iryna Bluemmert, et al.
Cell Reports|November 10, 2021
TNF leads to mtDNA release and cGAS/STING-dependent interferon responses that support inflammatory arthritisJoschka Willemsen, Marie-Therese Neuhoff, Thomas Hoyler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 22, 2010
Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNASandesh Subramanya, Myriam Armant, Janelle R Salkowitz, et al.
The Lancet. Oncology|October 21, 2021
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trialCourtney D DiNardo, Andre C Schuh, Eytan M Stein, et al.
Blood|June 17, 2022
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trialStéphane de Botton, Pau Montesinos, Andre C Schuh, et al.
Pageof 2